Dendritic cell targeted HIV‐1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8⁺ T cells

By  

Immunity, Inflammation And Disease, Vol. 6, Iss. 1, 2018-03 ,pp. : 163-175

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human Dendritic Cell Interactions with Whole Recombinant Yeast: Implications for HIV-1 Vaccine Development

By Barron Michelle   Blyveis Naomi   Pan Samuel   Wilson Cara  

Journal of Clinical Immunology, Vol. 26, Iss. 3, 2006-05 ,pp. : 251-264

Springer Publishing Company

Access to resources Recommend Favorite

Progress in development and testing of novel recombinant vaccine platforms for HIV

By Weiner David  

Springer Seminars in Immunopathology, Vol. 28, Iss. 3, 2006-11 ,pp. : 195-196

Springer Publishing Company

Access to resources Recommend Favorite

Oral Recombinant Mycobacterium bovis Bacillus Calmette–Guérin Expressing HIV-1 Antigens as a Freeze-Dried Vaccine Induces Long-Term, HIV-Specific Mucosal and Systemic Immunity

By Kawahara M.   Hashimoto A.   Toida I.   Honda M.  

Clinical Immunology, Vol. 105, Iss. 3, 2002-12 ,pp. : 326-331

Academic Press

Access to resources Recommend Favorite

CD4 + T cell-mediated protection against a lethal outcome of systemic infection with vesicular stomatitis virus requires CD40 ligand expression, but not IFN- or IL-4

By Andersen C.   Jensen T.   Nansen A.   Marker O.   Thomsen A.R.  

International Immunology, Vol. 11, Iss. 12, 1999-12 ,pp. : 2035-2042

Oxford University Press

Access to resources Recommend Favorite